https://ph-ksp.com/the-us-pulmonary-hypertension-association-the-pha-celebrates-its-35th-anniversary-read-more-on-the-latest-edition-of-its-magazine-pathlight/ 2026-04-10T06:33:12Z PULMONARY HYPERTENSION en The US Pulmonary Hypertension Association, the PHA, celebrates its 35th anniversary this year, read more on the latest edition of its magazine Pathlight 2026-04-10T06:31:24Z Blog https://ph-ksp.com/inhibikase-therapeutics-begins-pivotal-phase-3-trial-in-pulmonary-arterial-hypertension-april-7-2026/ 2026-04-10T05:39:05Z PULMONARY HYPERTENSION en Inhibikase Therapeutics begins pivotal phase 3 trial in pulmonary arterial hypertension, April 7, 2026 2026-04-10T05:17:27Z Blog https://ph-ksp.com/review-of-pulmonary-arterial-hypertension-pah-research-in-2025-key-trends-and-what-they-mean-for-patients-pulmonary-therapeutics-april-6-2026/ 2026-04-10T06:25:03Z PULMONARY HYPERTENSION en Review of Pulmonary Arterial Hypertension (PAH) research in 2025: key trends and what they mean for patients, Pulmonary Therapy, April 8, 2026 2026-04-10T05:01:36Z Blog https://ph-ksp.com/allrock-bio-doses-first-patients-in-phase-2a-trial-of-roc-101-for-pulmonary-arterial-hypertension-pah-and-pulmonary-hypertension-with-interstitial-lung-disease-ild-ph-april-9-2026/ 2026-04-10T04:42:03Z PULMONARY HYPERTENSION en AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension with Interstitial Lung Disease (ILD-PH), April 9, 2026 2026-04-10T04:41:14Z Blog https://ph-ksp.com/pulmonary-hypertension-global-patient-survey-phgps/ 2026-04-08T02:55:15Z PULMONARY HYPERTENSION en Pulmonary Hypertension Global Patient Survey (PHGPS), key insights and campaign pack 2026-04-08T02:32:46Z Blog